Latoprost
Brand Name: Latoprost
Generic Name: Latanoprost
Active
Registration Number
DRP-8607
Dosage Form
Ophthalmic Solution
Issuance Date
October 3, 2022
Expiry Date
April 11, 2028
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength50 mcg/mL (0.005% w/v))
PackagingLDPE Dropper Bottle x 5 mL
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antiglaucoma (Prostaglandin Analogue)
A
Application
Automatic Renewal
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
LatanoprostActive
Monograph: Latanoprost